Focused Alpha LLC’s Amgen AMGN Stock Holding History

Focused Alpha LLC’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.15M	Buy	3,259 +1,183	+57%	+$422K	0.35%	56
2025 Q4	$679K	Buy	+2,076	New	+$659K	0.2%	99

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Focused Alpha LLC's AMGN Position: Q1 2026 in Review

Focused Alpha LLC increased its Amgen (AMGN) stake by 57% in Q1 2026, buying an estimated $422K and bringing the position to 3,259 shares worth $1.15M. The position accounts for 0.35% of the portfolio, ranked #56.

Focused Alpha LLC first reported a position in AMGN in Q4 2025 and has held it in 2 quarters since. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Focused Alpha LLC held 3,259 shares of Amgen worth $1.15M as of Q1 2026.
Focused Alpha LLC bought 1,183 Amgen shares in Q1 2026, an estimated $422K.
Amgen made up 0.35% of Focused Alpha LLC's portfolio in Q1 2026, its #56 holding.
Focused Alpha LLC first reported a position in Amgen in Q4 2025 and has held it in 2 quarters since.
3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Focused Alpha LLC's 13F filing for Q1 2026, filed 12 May 2026.